創業集團控股(02221.HK)預期2025財年淨虧損不超1億港元
格隆匯6月20日丨創業集團控股(02221.HK)公告,公司預期將於2025財年錄得公司擁有人應佔淨虧損不超過100,000,000港元,而截至2024年3月31日止年度則錄得公司擁有人應佔淨利潤約2,860,000港元。
與2024財年相比,董事會認爲,預期公司擁有人應佔期內純利轉爲淨虧損乃主要由於(其中包括)以下因素:(i)於2024財年因向聯營公司注資無形資產(即專利技術)而錄得一次性收益,但2025財年並無此項收益;(ii)投資物業的公平值虧損增加;(iii)由於2025財年大型建築工程項目擴張,導致行政開支上升;及(iv)金融及合約資產的預期信貸虧損增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.